Načítá se...
Children's Oncology Group's 2013 Blueprint for Research: Acute Myeloid Leukemia
For the 365 children diagnosed with acute myeloid leukemia in the US annually, 5-year survival for patients on COG trials with low, intermediate, and high risk disease is 83%, 62%, and 23%, respectively. Recent advances include improved therapeutic stratification, improved survival with dose intensi...
Uloženo v:
| Vydáno v: | Pediatr Blood Cancer |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2012
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4605815/ https://ncbi.nlm.nih.gov/pubmed/23255301 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pbc.24432 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|